Simponi Aria® (golimumab) – New indications
October 20, 2017 – Janssen announced the FDA approval of Simponi Aria (golimumab) infusion, for the treatment of adults with active psoriatic arthritis (PsA) or active ankylosing spondylitis (AS).
Download PDF
